A Phase 2a Multicenter Clinical Trial of TB006 in Participants With Parkinson's Disease
Public ClinicalTrials.gov record NCT06773962. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2a, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of TB006 in Participants With Parkinson's Disease
Study identification
- NCT ID
- NCT06773962
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- TrueBinding, Inc.
- Industry
- Enrollment
- 62 participants
Conditions and interventions
Conditions
Interventions
- Placebo Drug
- TB006 Drug
Drug
Eligibility (public fields only)
- Age range
- 50 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 19, 2025
- Primary completion
- Nov 27, 2026
- Completion
- Nov 27, 2026
- Last update posted
- Apr 22, 2026
2025 – 2026
United States locations
- U.S. sites
- 14
- U.S. states
- 10
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Parkinson's Research Centers of America - Orange County | Aliso Viejo | California | 92656 | — |
| Parkinson's Research Centers of America - Palo Alto | Palo Alto | California | 94301 | — |
| CenExel Rocky Mountain Clinical Research | Englewood | Colorado | 80113 | — |
| Parkinson's Disease and Movement Disorders Center of Boca Raton | Boca Raton | Florida | 33486 | — |
| University of Miami | Miami | Florida | 33136 | — |
| University of South Florida Parkinson's and Movement Disorders Center | Tampa | Florida | 33613 | — |
| Consultants in Neurology, Ltd | Northbrook | Illinois | 60062 | — |
| Josephson Wallack Munshower Neurology - Southeast | Indianapolis | Indiana | 46256 | — |
| University of Kansas Medical Center | Kansas City | Kansas | 66160 | — |
| Quest Research Institute | Farmington Hills | Michigan | 48334 | — |
| Parkinson's Research Centers of America - Long Island | Commack | New York | 11725 | — |
| NYU Langone Health | Patchogue | New York | 11772 | — |
| Oregon Health & Science University | Portland | Oregon | 97239 | — |
| Central Texas Neurology Consultants | Round Rock | Texas | 78681 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06773962, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 22, 2026 · Synced May 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06773962 live on ClinicalTrials.gov.